文献速递系统性红斑狼疮其他结缔组织病

局部莫匹罗星治疗通过靶向葡萄球菌属减少皮肤型红斑狼疮皮损中的干扰素和髓系信号特征

Topical Mupirocin Treatment Reduces Interferon and Myeloid Signatures in Cutaneous Lupus Erythematous Lesions Through Targeting of Staphylococcus Species.
PubMed 文献 · Arthritis Rheumatol · 2025-01-23

该概念验证研究将12例活动性皮肤型红斑狼疮(CLE)皮损患者随机分配至2%莫匹罗星或凡士林赋形剂局部治疗7天,治疗前后采集皮损及鼻前庭微生物样本与皮损活检行16S rRNA基因测序和bulk RNA测序。莫匹罗星组鉴定出173个差异表达基因,皮损葡萄球菌负荷下降与IFN通路信号、炎症基因表达及屏障功能障碍下降相关,且莫匹罗星降低皮肤单核细胞水平并与炎症基因表达下降相关。作者认为局部抗生素可能通过减少葡萄球菌定植来减轻狼疮皮肤炎症和I型IFN反应。

要点

  • 12例活动性CLE皮损患者随机接受2%莫匹罗星或凡士林局部治疗7天。
  • 莫匹罗星组皮损中鉴定出173个差异表达基因。
  • 皮损葡萄球菌负荷下降与IFN通路信号及炎症基因表达下降相关。

核心结论

  • 莫匹罗星治疗减少皮损葡萄球菌,并与IFN信号和炎症基因表达下降相关。
  • 作者认为局部抗生素可通过减少葡萄球菌定植来减轻狼疮皮肤炎症和I型IFN反应。

研究设计与样本

  • 概念验证研究,招募12例活动性CLE皮损患者,随机分配至2%莫匹罗星或凡士林赋形剂局部治疗7天。
  • 治疗前后采集配对样本,鼻前庭和皮损微生物样本用于16S rRNA基因测序确定基线及治疗后葡萄球菌丰度和微生物群落谱。
  • 皮损活检行bulk RNA测序评估炎症反应。

主要发现

  • 局部莫匹罗星治疗后CLE皮损中鉴定出173个差异表达基因。
  • 皮损葡萄球菌负荷下降与IFN通路信号、炎症基因表达及屏障功能障碍下降相关。
  • 莫匹罗星治疗降低皮肤单核细胞水平,该单核细胞减少与炎症基因表达下降相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cutaneous lupus erythematosus (CLE) is an inflammatory skin manifestation of systemic lupus erythematosus. Type I interferons (IFNs) promote inflammatory responses and are elevated in CLE lesions. We recently reported that CLE lesions are frequently colonized with Staphylococcus aureus. Here, we follow up via a proof-of-concept study to investigate whether type I IFN and inflammatory gene signatures in CLE lesions can be modulated with mupirocin, a topical antibiotic treatment against S aureus-mediated skin infections. METHODS: Participants with active CLE lesions (n = 12) were recruited and randomized into a week of topical treatment with either 2% mupirocin or petroleum jelly vehicle. Paired samples were collected before and after seven days of treatment to assess microbial lesional skin responses. Microbial samples from nares and lesional skin were used to determine baseline and posttreatment Staphylococcus abundance and microbial community profiles by 16S ribosomal RNA gene sequencing. Inflammatory responses were evaluated by bulk RNA sequencing of lesional skin biopsies. RESULTS: We identified 173 differentially expressed genes in CLE lesions after topical mupirocin treatment. Decreased lesional Staphylococcus burden correlated with decreased IFN pathway signaling and inflammatory gene expression and barrier dysfunction. Interestingly, mupirocin treatment lowered skin monocyte levels, and this mupirocin-associated depletion of monocytes correlated with decreased inflammatory gene expression. CONCLUSION: Mupirocin treatment decreased lesional Staphylococcus, and this correlated with decreased IFN signaling and inflammatory gene expression. This study suggests a topical antibiotic could be employed to decrease lupus skin inflammation and type I IFN responses by reducing Staphylococcus colonization.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Abernathy-Close L, Mears J, Billi AC, et al. Topical Mupirocin Treatment Reduces Interferon and Myeloid Signatures in Cutaneous Lupus Erythematous Lesions Through Targeting of Staphylococcus Species. Arthritis Rheumatol. 2025. PMID: 39648343. doi:10.1002/art.43079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。